ZNF844 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.10782519111308E-14 |
Normal-vs-Stage2 |
1.41180000023944E-07 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
5.495200E-01 |
Stage1-vs-Stage3 |
6.73590072608476E-11 |
Stage1-vs-Stage4 |
3.77899999959297E-07 |
Stage2-vs-Stage3 |
2.603700E-03 |
Stage2-vs-Stage4 |
4.463700E-03 |
Stage3-vs-Stage4 |
8.547200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62470037423645E-12 |
Normal-vs-AfricanAmerican |
8.43769498715119E-15 |
Normal-vs-Asian |
2.704100E-03 |
Caucasian-vs-AfricanAmerican |
8.337400E-01 |
Caucasian-vs-Asian |
6.216600E-01 |
AfricanAmerican-vs-Asian |
5.448200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62470037423645E-12 |
Normal-vs-Female |
1.11022302462516E-16 |
Male-vs-Female |
9.569400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.86406445834564E-12 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
4.04376532259221E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.130810E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.755800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.953400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.675200E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.346240E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.714600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.681300E-03 |
Normal-vs-Grade 2 |
1.67488245494951E-12 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
1.196030E-01 |
Grade 1-vs-Grade 3 |
1.444700E-03 |
Grade 1-vs-Grade 4 |
1.775860E-03 |
Grade 2-vs-Grade 3 |
2.173000E-04 |
Grade 2-vs-Grade 4 |
1.54079971004251E-10 |
Grade 3-vs-Grade 4 |
5.180300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.65267799445701E-12 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
1.824490E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62558855265615E-12 |
Normal-vs-N1 |
5.87307980026708E-14 |
N0-vs-N1 |
2.744100E-03 |
|
|